Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: A Pragmatic Multicentre Randomised Placebo Controlled Trial

D. B. Price, S. Cotton, S. Fielding, N. McMeekin, P. Barnes, A. Briggs, G. Burns, R. Chaudhuri, H. Chrystyn, L. Davies, A. De Soyza, S. Gompertz, J. Haughney, A. Lee, A. Morice, J. Norrie, A. Sullivan, A. Wilson, G. Devereux

Research output: Contribution to journalAbstractpeer-review

18 Downloads (Pure)
Original languageEnglish
Article numberA7709
Number of pages2
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume197
Publication statusPublished - May 2018
EventAmerican Thoracic Society 2018 International Conference - San Diego Convention Center, San Diego, United States
Duration: 18 May 201823 May 2018

Bibliographical note

This abstract is funded by: National Institute for Health Research Health Technology Assessment

Presented at mini symposium:
B14. LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD
Monday 21st May 2018

Cite this